Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association. [electronic resource]
Producer: 20161223Description: 57 p. digitalISSN:- 1476-511X
- Aged
- Cholesterol Ester Transfer Proteins -- blood
- Cholesterol, LDL -- blood
- Diabetes Mellitus, Type 2 -- blood
- Female
- Gene Expression Regulation -- drug effects
- Hep G2 Cells -- drug effects
- Humans
- Hydrocarbons, Fluorinated -- pharmacology
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypercholesterolemia -- drug therapy
- Liver X Receptors -- blood
- Male
- Middle Aged
- Quinolines -- pharmacology
- Sulfonamides -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.